Merck & Co and Schering-Plough deal faces J&J hurdle to protect billions
This article was originally published in Scrip
Executive Summary
Johnson & Johnson has surfaced as a possible thorn in the side of Merck & Co's $41.1 billion takeover of Schering-Plough.